Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) — Financial Flexibility Index
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has a Financial Flexibility Index of -0.01x as of December 2025. Free cash flow of CN¥-44.49 Million (operating CF CN¥-149.12 Million minus capex CN¥104.63 Million) represents 0% of total liabilities (CN¥4.74 Billion). Also explore how fast is Hunan Dajiaweikang Pharmaceutical Indust growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd across 7 annual periods. Check asset resilience ratio of Hunan Dajiaweikang Pharmaceutical Indust to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2019–2025)
Year-by-year free cash flow to debt coverage for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd. For the full company profile including market capitalisation, see Hunan Dajiaweikang Pharmaceutical Indust (301126) total market value.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.01x | CN¥-44.49 Million | CN¥-149.12 Million | CN¥4.74 Billion | ▼ -119.2% |
| 2024 | 0.05x | CN¥211.18 Million | CN¥24.04 Million | CN¥4.33 Billion | ▼ -32.8% |
| 2023 | 0.07x | CN¥253.83 Million | CN¥27.13 Million | CN¥3.50 Billion | ▲ +153.8% |
| 2022 | -0.13x | CN¥-285.24 Million | CN¥-493.96 Million | CN¥2.11 Billion | ▼ -38.1% |
| 2021 | -0.10x | CN¥-128.52 Million | CN¥-161.81 Million | CN¥1.32 Billion | ▼ -7.5% |
| 2020 | -0.09x | CN¥-105.52 Million | CN¥-151.46 Million | CN¥1.16 Billion | ▼ -156.0% |
| 2019 | 0.16x | CN¥168.42 Million | CN¥135.91 Million | CN¥1.04 Billion | — |